ID

36389

Beskrivning

Study of Anlotinib in Patients With Metastatic Colorectal Cancer(mCRC)(ALTER0703); ODM derived from: https://clinicaltrials.gov/show/NCT02332499

Länk

https://clinicaltrials.gov/show/NCT02332499

Nyckelord

  1. 2019-05-09 2019-05-09 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

9 maj 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Metastatic Colorectal Cancer NCT02332499

Eligibility Metastatic Colorectal Cancer NCT02332499

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. signed and dated informed consent;
Beskrivning

Informed Consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
2. histological or cytological documentation of adenocarcinoma of the colon or rectum;
Beskrivning

Adenocarcinoma of colon | Adenocarcinoma of rectum

Datatyp

boolean

Alias
UMLS CUI [1]
C0338106
UMLS CUI [2]
C0149978
3. subjects with metastatic colorectal cancer (stage iv),with measurable disease (using recist1.1);
Beskrivning

Colorectal cancer metastatic TNM clinical staging | Measurable Disease

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0948380
UMLS CUI [1,2]
C3258246
UMLS CUI [2]
C1513041
4. progression during or within 3 months following the last administration of approved standard therapies which must include fluorouracil or its derivatives, oxaliplatin, irinotecan;
Beskrivning

Disease Progression Following Standard therapy | Fluorouracil | Fluorouracil Derivative | oxaliplatin | irinotecan

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0332282
UMLS CUI [1,3]
C2936643
UMLS CUI [2]
C0016360
UMLS CUI [3,1]
C0016360
UMLS CUI [3,2]
C1527240
UMLS CUI [4]
C0069717
UMLS CUI [5]
C0123931
5. ecog ps:0-1,life expectancy of more than 3 months;
Beskrivning

ECOG performance status | Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0023671
6. main organs function is normal;
Beskrivning

Organ function

Datatyp

boolean

Alias
UMLS CUI [1]
C0678852
7. main organs function is normal;
Beskrivning

Organ function

Datatyp

boolean

Alias
UMLS CUI [1]
C0678852
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. prior treatment with anlotinib;
Beskrivning

anlotinib

Datatyp

boolean

Alias
UMLS CUI [1]
C4519250
2. major surgical procedure, open biopsy, or significant traumatic injury within 28 days before start of study drug;
Beskrivning

Major surgery | Incisional biopsy | Traumatic injury

Datatyp

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2]
C0184922
UMLS CUI [3]
C3263723
3. known brain metastases;
Beskrivning

Metastatic malignant neoplasm to brain

Datatyp

boolean

Alias
UMLS CUI [1]
C0220650
4. patients with severe and failed to controlled diseases;
Beskrivning

Disease Severe Uncontrolled

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0205318
5. patients occurred venous thromboembolic events within 6 months;
Beskrivning

Thromboembolism of vein

Datatyp

boolean

Alias
UMLS CUI [1]
C1997614

Similar models

Eligibility Metastatic Colorectal Cancer NCT02332499

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
1. signed and dated informed consent;
boolean
C0021430 (UMLS CUI [1])
Adenocarcinoma of colon | Adenocarcinoma of rectum
Item
2. histological or cytological documentation of adenocarcinoma of the colon or rectum;
boolean
C0338106 (UMLS CUI [1])
C0149978 (UMLS CUI [2])
Colorectal cancer metastatic TNM clinical staging | Measurable Disease
Item
3. subjects with metastatic colorectal cancer (stage iv),with measurable disease (using recist1.1);
boolean
C0948380 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2])
Disease Progression Following Standard therapy | Fluorouracil | Fluorouracil Derivative | oxaliplatin | irinotecan
Item
4. progression during or within 3 months following the last administration of approved standard therapies which must include fluorouracil or its derivatives, oxaliplatin, irinotecan;
boolean
C0242656 (UMLS CUI [1,1])
C0332282 (UMLS CUI [1,2])
C2936643 (UMLS CUI [1,3])
C0016360 (UMLS CUI [2])
C0016360 (UMLS CUI [3,1])
C1527240 (UMLS CUI [3,2])
C0069717 (UMLS CUI [4])
C0123931 (UMLS CUI [5])
ECOG performance status | Life Expectancy
Item
5. ecog ps:0-1,life expectancy of more than 3 months;
boolean
C1520224 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
Organ function
Item
6. main organs function is normal;
boolean
C0678852 (UMLS CUI [1])
Organ function
Item
7. main organs function is normal;
boolean
C0678852 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
anlotinib
Item
1. prior treatment with anlotinib;
boolean
C4519250 (UMLS CUI [1])
Major surgery | Incisional biopsy | Traumatic injury
Item
2. major surgical procedure, open biopsy, or significant traumatic injury within 28 days before start of study drug;
boolean
C0679637 (UMLS CUI [1])
C0184922 (UMLS CUI [2])
C3263723 (UMLS CUI [3])
Metastatic malignant neoplasm to brain
Item
3. known brain metastases;
boolean
C0220650 (UMLS CUI [1])
Disease Severe Uncontrolled
Item
4. patients with severe and failed to controlled diseases;
boolean
C0012634 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
Thromboembolism of vein
Item
5. patients occurred venous thromboembolic events within 6 months;
boolean
C1997614 (UMLS CUI [1])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial